$30.57M | |
$14.79 | |
$4,900.00 | |
$3.66 | |
$14.00 | |
-- | |
0.00% | |
19K |
Apollomics Inc. (APLM) is currently trading at $14.25 as of 2026-06-05 20:11:00, reflecting a 0.00% move ($-0.00) from the previous close.
In the short term, the stock has returned -10.38% over the past four weeks. Over the last 12 months, Apollomics Inc. has recorded a +119.23% price change, indicating a Strong performance relative to the broader market.
Over the past seven days, Apollomics Inc. has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $14.20 to the latest recorded price of $14.25, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (19,054), investor positioning, and reactions to macroeconomic updates.
From a momentum standpoint, APLM has delivered a -10.38% return over the past month and a +119.23% change in the last 12 months, indicating a Strong trend relative to its broader sector peers.
You can buy and trade APLM on MEXC in three simple steps:
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.
| Industry | -- |
| Employees | 15 |
| Sector | -- |
| Company Website |
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Amount
1 APLM = 14.25 USD